bioecon Member area
Suppliers · Producer · Discovered — similar established company

Botswana Vaccine Institute

active BotswanaAfrica & Middle East Founded 1978 Unlisted Revenue: P162 million (FY 2024) checked 2026-10-05

Profile

Industry
Fishery & aquaculture, Veterinary
Topics
Animal & aquaculture vaccines
Role
Producer — “…ned veterinary research and manufacturing organization based in Gaborone, Botswana [1][2]. Founded in 1978, it…”
Parent / group
Government of Botswana
Why it is bioeconomy
The Botswana Vaccine Institute is a government-owned company that researches and manufactures veterinary vaccines for livestock disease control.
Found via
[Gap] Botswana · agri; [Gap] Botswana · food

Bio-solutions it supplies 0

Not yet cited as a supplier in a graded solution.

What they offer

This company does not publish its products or services — we find out through an introduction.

News & status 6

  • 2026-06 Latest status: The institute underwent a mandatory production shutdown for maintenance and sterilisation in 2026. ↗ ↗ ↗
  • Status review: active — Multiple dated 2026 sources: P300m plant revamp fast-tracked (Mar-Jun 2026), fresh FMD vaccine supply and regional response (May-Jun 2026), press releases through Aug 2026. The reduced-operations flag reflects a temporary maintenance shutdown during the revamp, not a sustained reduction.
  • 2026-06-19 BVI fast-tracks plant revamp :: Mmegi Online
    The Botswana Vaccine Institute (BVI) has initiated a P23 million revamp of its Gaborone production facilities, awarding Fabtech Technologies to upgrade to GMP-compliant infrastructure, HVAC, clean utilities, and critical MEP services for scalable vaccine …
  • 2026-02-18 VP Tours BVI as FMD threat looms | Government of Botswana
    The Botswana Vaccine Institute (BVI) is central to Botswana’s FMD containment effort, with the VP noting its role in protecting the national herd and economic stability; however, it currently faces a gap between the need (about 43 million vaccine doses) and …
  • 2026-03-09 BVI kickstarts new P300m plant :: Mmegi Online
    The Botswana Vaccine Institute (BVI) is advancing a P300 million expansion, including a new blending and filling lab and an antigen bank, aiming to boost production capacity and expand into Middle Eastern markets by 2027.
  • 2026-05-21 H.E. President Ramaphosa commends BVI’s continental contribution to Vaccine Excellence and Animal Health - Botswana Vaccine Institute
    The Botswana Vaccine Institute (BVI) is highlighted as a strategic regional asset in animal health and livestock disease control, receiving high-level recognition from South Africa’s President for its vaccine excellence and biosecurity contributions in the …
  • 2026-01-23 FOR IMMEDIATE RELEASE: Botswana Vaccine Institute: Supporting Regional FMD Crisis Response - Botswana Vaccine Institute
    The Botswana Vaccine Institute (BVI) is actively responding to the regional FMD outbreak by deploying technical support to Eswatini and other affected countries, reflecting its commitment to regional animal health, resilience, and strategic partnerships. It …
  • 2026-06-08 PRODUCTION SETBACKS COST BVI KEY SOUTH AFRICAN ORDERS – The Business Weekly & Review
    Botswana Vaccine Institute (BVI) is expanding capacity (investing in automated blending/filling to raise output from ~25m to ~30m doses/year) but is currently under strain, with production disruptions causing regional vaccine supply gaps and pushed South …

Network: owners, partners, peers

Ownership & investors 1

parentGovernment of Botswana

Similar companies

Kenya Veterinary Vaccines Production Institute (KEVEVAPI) · MEVAC for Vaccines · Vaccine Valley · LABORATOIRE CENTRAL VETERINAIRE DU MALI · Deltamune · Klybeck Life Sciences MENA · national veterinary institute nvi ethiopia · International Free Trade Corporation - IFT

Identity & contacts

Contacts, people and legal identity are available to members.

Sign in as a member